T 細胞 が 酸素 を 感知 する こと に よっ て,免疫 面 で 許容 できる 転移 的 な 基層 が 形成 さ れ ます
David Clever1, Rahul Roychoudhuri2, Michael G Constantinides3
1Surgery Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA; Medical Scientist Training Program, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Cell
|August 28, 2016
まとめ
T細胞のプロリルヒドロキシラーゼ (PHD) タンパク質は,抗腫瘍免疫を抑制することによって肺転移を促進します. PHDタンパク質を阻害することで,がんの拡散を抑制し,肺における免疫療法の有効性を高めます.
科学分野:
- 免疫学
- 癌 生物学
- 肺医学
背景:
- 癌の転移,特に肺への転移は 免疫の回避を必要とする.
- 肺に特有の免疫メカニズムは腫瘍の植民を容易にする可能性があります.
- この文脈におけるT細胞における酸素感受性プロリルヒドロキシラーゼ (PHD) タンパク質の役割は不明である.
研究 の 目的:
- 肺転移におけるT細胞内部のPHDタンパク質の役割を調査する.
- PHDタンパク質が腫瘍植民期中に肺の免疫微環境にどのように影響するかを決定する.
主な方法:
- PHDタンパク質のT細胞特異の削除による遺伝子組み換えマウスモデルを使用した.
- PHDタンパク質の薬学的な阻害を施した.
- 肺の免疫細胞集団 (Tヘルパー1,調節性T細胞,CD8+T細胞) とサイトカインプロファイル (IFN-γ) を分析した.
主要な成果:
- T細胞内在のPHDタンパク質は肺転移を許可するのに不可欠です.
- PHDタンパク質はTヘルパー1の反応を制限し,T細胞の調節誘導を促進し,肺のCD8+T細胞機能を抑制する.
- PHDの抑制により,腫瘍のコロニー化が減り,受容細胞移植の免疫療法の有効性が向上した.
結論:
- T細胞のPHDタンパク質は 肺の免疫反応を指揮し 癌の転移を可能にします
- PHDタンパク質を標的にすることは,肺転移と闘い,がん免疫療法を強化するための潜在的な治療戦略です.
関連する概念動画
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K


